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Emphysematous cholecystitis: A rare
complication of hepatitis A virus infection
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Background: Acute hepatitis A virus infection, is a common
infection, seen especially in childhood, in developing countries and
is usually asymptomatic however rarely it can present with extra-
hepatic manifestations.A 22-year old male presented to a primary
care center with fever, nausea and vomiting and received a diagno-
sis of an upper respiratory tract infection. Four days after the onset
of complaints, the patient’s urine color darkened (tea color), and
jaundice in the sclera was noticed.
Methods & Materials: In his abdominal examination, his liver
crossed over the midclavicular line about 3 cm. There was sig-
niﬁcant pain and tenderness in the upper right quadrant. In
laboratory evaluation the following ﬁndings were present; WBC
count 11000/mm3, AST 559U/L, ALT 1830U/L, ALP 357U/L, GGT
327U/L, direct bilirubin 8,71mg/dL, total bilirubin 16,09mg/dL,
albumin 3.85mg/dL, prothrombin time(PT) 17.4 seconds, INR 1.26,
bilirubin and urobilinogen in the urine (++++).
Results: An abdominal ultrasonography was performed which
revealed that the liver was 174mm, with a grade 1 diffusely
increased parenchyme echo. Also, free ﬂuid was present in the
pelvic and perihepatic areas. The wall of the GB was measured as
14.6 mm(N:3mm)(Image 1). There was intramural air present in
the wall of the GB. Also in the pericholecystic area, a reticular het-
erogenous hypoechoic structure, 15mm in diameterwas observed.
In the light of these ﬁndings, a diagnosis of emphysematous chole-
cystitis was established, and parenteral ampicilin-sulbactam was
initiated empirically. In serological evaluations that were con-
ducted to ﬁnd out the etiology of the acute hepatitis presentation,
HBsAg, anti-HBc IgM, anti-HBc IgG, anti-HCV tests were nega-
tive. However anti-HAV IgM and anti-HAVIgG was positive. Within
48hours of the patient’s admission, as there was no improvement
in the patient’s clinical status, and an increase in the abdominal
pain, a laparascopic cholecystectomy was performed. Twenty days
after the operation the patients laboratory ﬁndings, abdominal USG
and liver tests were normal.
Conclusion: To sum up, HAV infection can be seen in all age
groups, in developing countries, such as our country. It must be
kept inmind that, although very rarely, HAV infectionsmay exhibit
extrahepatic complications.
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Association between HLA-G 14-pb
Insertion/Deletion Polymorphism and hepatitis
B viral infection: A Case-control study of a
central Tunisian population
J. Boukadida
CHU Farhat Hached, Sousse, Tunisia
Background: Chronic infection with hepatitis B virus is a
major cause of liver pathologies. Increasing evidence indicates
that immunological and host genetic factors inﬂuence hepatitis B
infection’s outcome.The human leukocyte antigen (HLA)-G plays
an important role in immune response regulation. Because of
the implication of HLA-G in viruses’ immune escape, we tested
the 14-bp Insertion/Deletion (Ins/Del) polymorphism (rs1704) of
3’UTRHLA-G gene association to HBV infection.
Methods & Materials: Included 150 Tunisian chronic hepatitis
B case patients (75 males and 75 females; Mean age 36.45±10.59
years and 150 healthy control subjects (75 males and 75 females;
Mean age 34.19±10.75 years). Genotyping for the 14-bp Ins/Del
polymorphism was performed by polymerase chain reaction(PCR).
Statistical analysis was performed using SPSS version 17.0. The
odds ratio (OR) and 95% conﬁdence interval (CI) were calculated
to estimate the relative risk.P value. Level of signiﬁcance was set at
0.05.
Results: We found that 27.3% (n=41) of patients and 29.3%
(n=44) of controls were homozygous for the Del allele; and 38%
of patients (n =57) and 44% of cases (n =66) were heterozygous
(P=0.31).The genotypes were consistent with Hardy-Weinberg
equilibrium (X2 =2.14 andP=0.14). The alleles frequencies were
not statistically different (46.3% for the Del allele versus 51.3%
for healthy controls; P=0.22). When we stratiﬁed according to
HBV viral activity (82 patients with non/low viral replication and
68 patients with active viral replication; Threshold =2000IU), we
reported statistical signiﬁcant differences in the alleles’ frequen-
cies (P=0.019, OR=1.7, 95% CI: 1.08-2.7).The Del allele frequency
was evaluated to 52.4% in patients with non/low viral replica-
tion and to 39% in patients with active replication.We also found
a statistical signiﬁcant difference (P=0.04; OR=0.45 and 95% CI:
0.21-0.97) in the distribution of Del/Del genotype between the two
patients’ subgroups compared with the Ins/Ins and Del/Ins geno-
types (34.1% and 19.1%, respectively in non/low-and active viral
replication patients).
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Conclusion: The data suggest that the HLA-G 14-pb Ins/Del
polymorphism may not play a relevant role in the susceptibilityto
hepatitis B infection. However, the association between this poly-
morphism and infection severity suggests an evidence of HLA-G
implication in hepatitis B infection progression.
http://dx.doi.org/10.1016/j.ijid.2014.03.1063
Type: Poster Presentation
Final Abstract Number: 57.003
Session: Virology and Viral Infections (Non-HIV) I
Date: Friday, April 4, 2014
Time: 12:45-14:15
Room: Ballroom
Hepatitis B core IgM antibodies (anti HBcIgM), a
serological marker for eradicating transfussion
associated hepatitis B virus (TAHBV) infection in
low income countries
M.O. Japhet
Obafemi Awolowo University, Ile-Ife, Nigeria, Osun
State, Nigeria
Background: The safety of blood products is one of the major
problems concerned with the transfusion medicine. A deﬁnite haz-
ard of transmission of hepatitis B to recipients of blood screen
for Hepatitis B surface Antigen (HBsAg) when such donor is at
the ‘window phase’ exist. The possibility of achieving zero risk
of Transfusion Associated Hepatitis B Virus (TAHBV) infection is
highly dependent on DNA testing of all collected units of blood
before transfusion. This is not feasible in low income countries
including Nigeria due to cost. At present, HBsAg detection is the
only diagnostic screening test for HBV infection identiﬁcation in
the blood transfusion centers of Nigeria. Hepatitis B core IgM anti-
body (anti-HBc IgM) is gaining prominence as a useful alternative
in reducing TAHBV infection. The present study was aimed at eval-
uating adoption of anti-HBc IgM an additional screening assay
for blood donation since anti-HBc detection is not mandatory in
Nigeria.
Methods & Materials: Two hundred and seventy-three
(Male =246, F =27; Age range:18-50 Mean:24.9years) apparently
healthy blood donors in Ibadanwere enrolled in the study between
October andDecember2012; their demographicdatawasobtained.
The frequency of HBsAg and its corresponding antibody (HBsAb),
as well as Hepatitis B envelope antigen and its corresponding anti-
body (HBeAg and Ab) were assessed using standard enzyme link
Immunosorbent assay EELISA) technique. Anti-HBcIgM was also
assessed in donors negative or positive for HBsAg using same
method.
Results: The prevalence of anti-HBc IgM was 4.4%. Twelve (11
Males and 1 female) had anti-HBc IgM as the only marker of HBV
infection. Prevalence of HBsAg, HBsAb, HBeAg and HBeAb were
14(5.1%), 95(34.8%), 2(14.3%) and 3(21.4%) respectively.
Conclusion: The ﬁndings of the current study recommends that
all blood units should be tested for anti -HBc IgM to understand the
infectivity status of the blood donors in the window period and to
discardblood if zero risk of TransfusionAssociatedHepatitis BVirus
(TAHBV) infection will be achieved in Nigeria.
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Hepatocellular carcinoma in a long-term
sustained virological responder following
pegylated-interferon plus ribavirin
combination therapy for chronic hepatitis C
E. Gunal1, M.K. Celen2
1 Diyarbakir Military Hospital, Diyarbakir, Turkey
2 Dicle University Medical Faculty, Diyarbakir,
Turkey
Background: It is well known that long-term complications of
hepatitis C virus (HCV) infection including hepatocellular carci-
noma (HCC) and cirrhosis are eliminated or decrease in sustained
virological responders after treatment. We report a case from
Turkey who developed HCC 4 years after sustained and complete
response to pegylated interferon plus ribavirin combination ther-
aphy.
Methods & Materials: A 60-year-old man with HCV genotype
1b was treated with pegylated interferon alpha-2b in combination
with ribavirin for a total of 52weeks. Initially, his liverhistologywas
consistent with amild activity and 1\6 ﬁbrosis stage due to chronic
hepatitis C. After 28 weeks of treatment, aminotransferase levels
were in the normal range and HCV RNA (polymerase chain reac-
tion) was undetectable in serum. Sustained and complete response
were obtained with normalization of aminotransferases and dis-
appearance of HCV RNA in serum continuously. HCV-RNA was also
not detected in the liver tissue after treatment, but histopatholog-
ical examination was the same as before. He followed up for HCC
based on biochemical and ultrasound evaluation every 6 months.
Results: HCC was detected 48 months after cessation of
therapy with the elevation of serum aminotransferases and alpha-
fetoprotein for the ﬁrst time, then splenomegaly and acid were
revealed by ultrasonography. HCC was diagnosed by computed
tomography and angiography, and then treated through transarte-
rial embolization but patient died of liver failure within 2 months.
Conclusion: Successful treatment in our case didn’t prevent
development of HCC even in non-cirrhotic liver. Our case indicates
the importance of not underestimating risk of HCC development
even many years after sustained and complete response to HCV
treatment. Long-term follow up are always mandatory and should
include more carefully and closely surveillance for HCC.
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